| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.6 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |